HBV genotypes and antiviral therapy of hepatitis B
At least 600 thousand individuals infected with hepatitis B virus (HBV) die annually worldwide due to liver cirrhosis and hepatocellular carcinoma. To date, efficiency of antiviral therapy for HBV infection is limited, so the main goal of treatment is prevention of liver disease progression and not...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Zaslavsky O.Yu.
2019-09-01
|
| Rangatū: | Aktualʹnaâ Infektologiâ |
| Ngā marau: | |
| Urunga tuihono: | http://ai.zaslavsky.com.ua/article/view/178879 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|